Skip to contentSkip to sidebarSkip to footer
ONWARD
Menu Close
  • Home
  • About
    • About
    • Aims
    • Objectives
  • Members
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Restricted Access
  • Grants
    • STSM
    • Conference Grants
  • Scientific Outputs
    • Papers
    • Guidelines
    • Recommendations
  • Stakeholders
  • News
  • Events
  • Contact
Close
  • Home
  • About
    • About
    • Aims
    • Objectives
  • Members
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Restricted Access
  • Grants
    • STSM
    • Conference Grants
  • Scientific Outputs
    • Papers
    • Guidelines
    • Recommendations
  • Stakeholders
  • News
  • Events
  • Contact
Join Us
ONWARD
  • Home
  • About
    • About
    • Aims
    • Objectives
  • Members
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Restricted Access
  • Grants
    • STSM
    • Conference Grants
  • Scientific Outputs
    • Papers
    • Guidelines
    • Recommendations
  • Stakeholders
  • News
  • Events
  • Contact
News

ONWARD Presented at the World Hepatitis Summit in Bangkok

13 hours ago0Comments
ONWARD at the World Hepatitis Summit 2026 Our Action was recently represented at…
News

ONWARD Presented at the 35th APASL Annual Meeting in Istanbul

1 day ago0Comments
ONWARD Presented at the 35th APASL Annual Meeting in Istanbul The ONWARD was…
News

Sérgio Silva Completes ONWARD Short-Term Scientific Mission

3 days ago0Comments
Dr Sérgio Silva from REQUIMTE, University of Porto, Porto, Portugal, recently participated in…
News

ONWARD COST Action at ESCMID Global 2026 in Berlin

3 days ago0Comments
ONWARD Takes the Stage at ESCMID Global 2026 — The World's Largest Infectious…
News

Building a European Network for Zoonotic Hepeviruses

23.02.20260Comments
My journey with hepatitis E began during my postdoctoral period, when I first…
Search
Categories
  • Personal Growth
  • Psychology
  • Therapy Guides
  • Wellness Tips
Recent Posts
ONWARD Presented at the World Hepatitis Summit in Bangkok
News
ONWARD Presented at the World Hepatitis Summit in Bangkok
30.04.2026
ONWARD Presented at the 35th APASL Annual Meeting in Istanbul
News
ONWARD Presented at the 35th APASL Annual Meeting in Istanbul
29.04.2026
ONWARD

COST Action CA24140 | One Health zoonotic Hepevirus Network (ONWARD)

Linkedin Facebook Instagram
COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

  • www.cost.eu
COST Action Info

Complex challenges like hepatitis E and other zoonotic hepeviruses can only be addressed through collaboration across disciplines, from human and animal health to food safety, environmental science, and public health. This integrated, One Health perspective is essential for turning scientific knowledge into real-world impact.

  • Discover
COST Action Detail
  •  MoU – 049/25
  •  CSO Approval date – 19/05/2025
  •  Start date – 29/09/2025
  •  End date – 28/09/2029